Login to Your Account



Pharma: Clinic Roundup


Wednesday, June 5, 2013
• CSL Behring, of King of Prussia, Pa., dosed the first patient in Part 3 of its AFFINITY trial program.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription